<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE324nnn/GSE324519/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mus musculus</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE324519</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Differential gene expression induced by doxorubicin in tumor-bearing and non–tumor-bearing mice</name><description>Doxorubicin-related cardiotoxicity is a major concern in cancer therapy and is influenced by drug dose, administration regimen, and host condition. While chemotherapy occurs under tumor-bearing conditions in clinical practice, most experimental studies evaluate cardiotoxicity in non–tumor-bearing models, which may alter cardiac responses to doxorubicin.</description><dates><publication>2026/07/01</publication></dates><accession>GSE324519</accession><cross_references><GSM>GSM9578958</GSM><GSM>GSM9578947</GSM><GSM>GSM9578959</GSM><GSM>GSM9578948</GSM><GSM>GSM9578956</GSM><GSM>GSM9578945</GSM><GSM>GSM9578957</GSM><GSM>GSM9578946</GSM><GSM>GSM9578965</GSM><GSM>GSM9578954</GSM><GSM>GSM9578955</GSM><GSM>GSM9578963</GSM><GSM>GSM9578952</GSM><GSM>GSM9578964</GSM><GSM>GSM9578953</GSM><GSM>GSM9578961</GSM><GSM>GSM9578950</GSM><GSM>GSM9578962</GSM><GSM>GSM9578951</GSM><GSM>GSM9578960</GSM><GSM>GSM9578949</GSM><GPL>24247</GPL><GSE>324519</GSE><taxon>Mus musculus</taxon><PMID>[42352982]</PMID></cross_references></HashMap>